SCHEMBL27645783

SCHEMBL27645783

Nn1nc(Cl)cc1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.41
ALDH1A1 P00352 3/20 0.41
HTT P42858 1/20 0.41
KDM4E B2RXH2 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 3/20 0.38
ATP4A P20648 1/20 0.37
ATP4B P51164 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.36
HPGD P15428 2/20 0.36
MEN1 O00255 2/20 0.36
TP53 P04637 1/20 0.36
NUDT1 P36639 1/20 0.36
RPA1 P27694 2/20 0.36
GLA P06280 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26459294 0.78 MAPT (0.46) ALDH1A1HTTKDM4EL3MBTL1NPC1
SCHEMBL27645709 0.76 KDM4E (0.39) ALDH1A1KDM4EL3MBTL1NPC1RAB9A
SCHEMBL28318766 0.64 NUDT1 (0.40) LMNAALDH1A1HTTKDM4EL3MBTL1
SCHEMBL2875450 0.64 CLK4 (0.42) LMNAALDH1A1KDM4EL3MBTL1NPC1
SCHEMBL973230 0.63 KMT2A (0.50) ALDH1A1KDM4EL3MBTL1KMT2ANUDT1
SCHEMBL15716701 0.63 PTGER1 (0.43) LMNAALDH1A1HTTKDM4EL3MBTL1
SCHEMBL4000527 0.60 KDM4E (0.52) LMNAALDH1A1HTTKDM4EL3MBTL1
Fenclorim SCHEMBL20564320 0.58 LMNA (0.73) LMNAALDH1A1HTTKDM4EL3MBTL1
SCHEMBL8881198 0.58 PCSK9 (0.45) ALDH1A1KDM4EL3MBTL1KMT2ANUDT1
SCHEMBL23860768 0.57 KDM4E (0.53) LMNAALDH1A1HTTKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1913898-A Substituted piperazines CHEMOCENTRYX INC (US) 2007-02-14 CN disclosed